Thapsigargin (TG), by inducing perturbations in cellular Ca 2+ homeostasis, has been shown to induce apoptosis. The molecular mechanisms of Ca 2+ perturbation-induced apoptosis are not fully understood. In this study, we demonstrate for the ®rst time that TG-mediated perturbations in Ca 2+ homeostasis are coupled with activation of the death receptor 5 (DR5)-dependent apoptotic pathway in human cancer cells. TG selectively upregulated DR5 but had no eect on the expression of the other TRAIL receptor, DR4. TG also upregulated the expression of the DR5 ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand), albeit in a celltype speci®c manner. TG-induced apoptosis has been shown to be associated with activation of the mitochondrial pathway. We found that TG upregulation of DR5 and TRAIL was coupled with caspase 8 activation and Bid cleavage, suggesting that the TG-regulated DR5 pathway could be linked to the mitochondrial pathway. TG enhanced not only DR5 mRNA stability but also increased induction of the DR5 genomic promoterreporter gene. The TG-induced increase in DR5 expression appeared to occur as a consequence of TGinduced endoplasmic reticulum (ER) Ca 2+ pool depletion. Thus, we report our novel ®ndings that ER Ca 2+ pool depletion-induced apoptotic signals are mediated, at least in part, via a DR5-dependent apoptotic pathway and there appears to be a cross-talk between the death receptor and mitochondrial pathways.
Introduction
Apoptosis is a genetically controlled process that is essential for tissue homeostasis. Defects in regulation of apoptosis can contribute to a variety of diseases, including cancer. Recent studies have demonstrated that apoptosis is controlled through dierent signaling pathways that engage membrane death receptors and/ or the mitochondria (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998; Sheikh and Fornace Jr, 2000; Gross et al., 2000) . Tumor necrosis factor receptor 1 (TNF-R1) and Fas are the prototype cell surface membrane death receptors mediating apoptosis, and are activated by TNFa and FasL respectively (reviewed by Ashkenazi and Dixit, 1999; SchulzeOstho et al., 1998) . Other cell surface receptors that belong to this family of membrane death receptors include DR3, DR4 and DR5 (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998) . Apo3L is a ligand for DR3, whereas both DR4 and DR5 are activated by a common ligand named TRAIL (TNFrelated apoptosis inducing ligand). Each of these receptors contains an intracellular region designated as the death-domain, which is critical for the intracellular transmission of apoptotic signals. Ligand-dependent and -independent activation of these receptors involve multimerization, with subsequent recruitment of intracellular adaptor molecules to relay signals inside the cell (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998) . The apoptotic signals originating from these death receptors converge on the proximal caspase 8, and subsequently engage downstream caspases, leading to the cleavage of death substrates and ®nally cell death (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998) .
We have recently demonstrated that DR5 expression is induced by DNA damaging agents in both a p53-dependent and -independent manner (Sheikh et al., 1998a) . In our preliminary studies, we also found that DR5 mRNA levels were enhanced during thapsigragin (TG)-induced apoptosis. TG is a sesqueterpene lactone that inhibits the endoplasmic reticulum (ER) Ca
2+
ATPases (Sagara and Inesi, 1991) . TG-mediated inhibition of ER Ca 2+ ATPases abrogates the reuptake of cytosolic Ca 2+ into the ER. This in turn can cause an increase in cytoplasmic Ca 2+ levels and depletion of Ca 2+ within the ER (Sagara and Inesi, 1991) . Perturbations in cellular Ca 2+ homeostasis have been reported to induce apoptosis in both normal and malignant cells (Krebs, 1998) . In view of a central role of DR5-mediated signaling and Ca 2+ -dependent events in apoptosis, we undertook this study to investigate the molecular mechanisms of DR5 regulation during TGinduced apoptosis in human cancer cells. Figure 1a shows the morphologic features of TGinduced apoptosis in one representative HT29 human colon cancer cell line. As is shown, TG-treated cells exhibit characteristic features of apoptosis, including chromatin condensation and nuclear fragmentation ( Figure 1a) . Figure 1b depicts quantitative results regarding TG-induced apoptosis in several human cell lines of dierent lineages.
Results

TG-induced apoptosis is coupled with upregulation of DR5
DR5 has recently been identi®ed as a downstream eector of p53 (Wu et al., 1997) . We recently demonstrated that DR5 is regulated in both a p53-dependent and -independent manner in a variety of human cancer cell lines (Sheikh et al., 1998a) . We have found that DR5 is regulated in an agent-speci®c manner since not all apoptosis-inducing agents modulate DR5 expression (Sheikh et al., 1998a and our unpublished results) . TG, which is a potent inducer of apoptosis, is found to upregulate DR5 mRNA in all the cell lines tested so far. TG speci®cally regulates DR5, and has no eects on another TRAIL death receptor, i.e., DR4. Table I summarizes the eects of TG on DR5 mRNA levels in 10 human cancer cell lines of various lineages.
Representative Northern blots (Figure 2a) show the eects of TG on DR5 mRNA levels in three dierent cell lines. In addition, TG upregulates DR5 at the protein level, as demonstrated by Western blot analysis in Figure 2b . The TG-mediated induction of DR5 mRNA and protein occurs in a p53-independent manner since TG modulates their levels in both p53-positive and -negative cells (Table 1 and Figure 2 ).
TG regulation of DR5 ligand TRAIL
We next investigated whether TG also regulates the expression of DR5 ligand TRAIL. Since the TRAIL cDNA can cross-hybridize to several non-speci®c transcripts, we used RT ± PCR analysis to investigate TRAIL expression and regulation by TG. We found that some cell lines exhibit easily detectable levels of TRAIL transcripts while others express very low levels (Table 2 ). TG's eect on TRAIL mRNA expression was investigated in three dierent cell lines including HT29, MCF-7 and DU145. The results indicate that TG upregulates TRAIL expression in HT29 and MCF-7 cells but not in DU145 cells (Table 2) . Representative results for HT29 cells are shown in Figure 3 . It is of note that the extent of TRAIL upregulation is similar to that noted for DR5 in identical experiments ( Figure  3 ). Due to the unavailability of good anti-TRAIL antibodies, we could not determine the eects of TG on TRAIL at the protein level.
TG-induced apoptosis and upregulation of DR5 is coupled with activation of proximal and downstream caspases
Caspase 8 is one of the most proximal caspases that is activated by signals originating at the membrane death receptors, including DR5. We reasoned that if TG upregulation of DR5 and its ligand TRAIL results in the activation of this death receptor-dependent apoptotic pathway, then caspase 8 should also be activated. As seen in Figure 4a , TG does in fact activate caspase 8 in several of the cell lines tested. Caspase 8 activation involves cleavage of its pro-form into smaller active subunits, which results in decreased levels of the proform (Thornberry and Lazebnik, 1998; Orth et al., 1996; Sheikh et al., 1998b) . Thus, decreasing levels of pro-caspase 8 as a function of TG treatment re¯ects its activation (Figure 4a ). The active form of caspase 8 is known to cleave and activate downstream caspases such as caspases 3, 6 and 7, which in turn cleave various death substrates, including PARP (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998; Sheikh and Fornace Jr, 2000; Gross et al., 2000) . Our results indicate that TG-induced activation of caspase 8 is coupled with activation of caspase 3 ( Figure 4a ) and cleavage of the death substrate PARP (Figure 4b ). Taken together, these results suggest that TG, by regulating DR5 and in some cells its ligand TRAIL, can activate the death receptor 5 pathway.
TG-induced Bid cleavage: cross-talk between DR5 and mitochondrial pathway
In addition to death receptors, the mitochondria also play an important role in the regulation of apoptosis. In this regard, activation of caspase 9 is central to mitochondrial-dependent apoptosis (reviewed by Gross et al., 2000) . TG has recently been shown to engage the mitochondrial pathway to activate caspase 9 (Wertz and Dixit, 2000) . Our results con®rm these recently published ®ndings that TG can activate caspase 9 (Figure 4c ). Recent evidence suggests that apoptotic signals originating at the membrane death receptors can cross-talk with the mitochondrial pathway via Bid. Bid is a Bcl-2 family member that has been shown to be cleaved by caspase 8 following death receptor activation (Li et al., 1998; Luo et al., 1998) . We investigated whether Bid is cleaved during TG induced apoptosis. We reasoned that if cross-talk occurs between the DR5 and mitochondrial-mediated apoptotic pathways then TG should also induce Bid cleavage. Bid cleavage is generally assessed as a Figure 2 (a) The eect of thapsigargin (TG) on death receptor 5 (DR5) mRNA in three representative cancer cell lines. Northern blots show that TG increases DR5 mRNA levels in human colon (HT29), lung (A549) and breast (MCF-7) cancer cells. Cells were treated with vehicle (DMSO) alone as control (C) or TG for the time periods indicated in hours. Cells were exposed to 1 mM TG except for 4 h treatment in the case of HT29 cells. RNA extraction and Northern blot hybridizations were performed by standard methods. Ethidium bromide staining of the same gels shows RNA integrity and comparable loading. (b) TG eect on death receptor 5 (DR5) protein levels in representative human cancer cell lines. Cells were treated with vehicle (DMSO) alone as control (C) or TG (2 mM) for the time periods shown in hours. Western blotting was performed using a polyclonal anti-DR5 antibody (upper panel). To demonstrate comparable loading, the same blot was probed with an anti-b-actin antibody. The twoband pattern of DR5 protein is consistent with previously published results (Grith et al., 1999) Figure 5 , indicate that indeed TG can induce Bid cleavage. Thus, TG appears to exert its apoptotic eects through DR5 as well as the mitochondrial pathways suggesting that cross-talk between these two pathways occurs during TGmediated apoptosis.
TRAIL potentiates TG-induced cell killing
To further investigate the functional signi®cance of TGmediated upregulation of endogenous DR5 levels, we explored the eects of exogenous TRAIL on TGmediated apoptosis. We recently reported that 50 ng/ ml TRAIL induced apoptosis in several cell lines including DU145 and TSU-Pr1 cells (Huang et al., 2001) . However, at 5 ng/ml, TRAIL did not induce apoptosis in these cells (Huang et al., 2001) . Therefore, we utilized lower concentrations of TG and TRAIL in DU145, TSU-Pr1 and MCF-7 cell lines. As shown in Figure 6 , lower concentrations of TRAIL do not induce apoptosis but clearly potentiate TG-mediated apoptosis in all the cell lines tested. Since TG upregulates only one of the two TRAIL receptors, i.e. DR5 but not DR4, these results highlight the functional signi®cance of TGmediated upregulation of DR5.
Mechanism of TG-mediated upregulation of DR5 mRNA
TG could possibly upregulate DR5 mRNA levels by increasing the rate of DR5 gene transcription or Western blot analyses were performed using anti-Bid antibodies (R&D, Minneapolis, MN, USA). Decrease in the levels of Bid re¯ects Bid cleavage. To demonstrate comparable loading, the same blot was probed with an anti-b-actin antibody increasing DR5 mRNA stability or both. To investigate these alternatives, ®rst we investigated TG's eects on DR5 mRNA stability. The relative decay rates of the DR5 message were determined via Northern analysis in MCF-7 cells under basal conditions (i.e., cells not exposed to TG), and after they had been exposed to TG for 24 h (i.e., after induction of DR5 by TG). As shown in Figure 7 , in TG-untreated MCF-7 cells the DR5 mRNA decays with a t 1/2 of approximately 4 h after transcription is blocked with actinomycin D. On the other hand, in TG-treated MCF-7 cells the t 1/2 of DR5 mRNA is about 7 h (Figure 7) . Similar results were obtained in HT29 human colon cancer cells (data not shown). These data suggest that the TG-mediated upregulation of DR5 mRNA occurs, at least in part, via post-transcriptional control involving enhanced RNA stability. Next, we investigated the eect of TG on the DR5 genomic promoter-reporter gene. For this purpose, we utilized three genomic constructs representing parts of the DR5 gene as shown in Figure 8 . MCF-7 cells were transiently transfected with these reporter constructs, and luciferase assays were performed on the lysates of untreated or TG-treated cells. The results, presented in Figure 8 (lower panel), show that TG enhances luciferase reporter activity in these cells. It is of note that TG mediates its eects predominantly from the genomic construct containing the 5'-proximal promoter region and part of exon 1 (Figure 8 ). Taken together, our results indicate that TG upregulates DR5 mRNA via two mechanisms: (i) by increasing DR5 mRNA stability, and (ii) by enhancing DR5 promoter activity. transients in these cells if they are pre-treated with 2 mM TG for 4 h (Figure 9b ). This demonstrates that TG pre-treatment depletes the ER-releasable Ca released from the ER by TG (Figure 9d) . A short exposure to BAPTA-AM (20 mM) is sucient in preventing TG-mediated Ca 2+ transients since removal of HT29 cells from BAPTA-AM containing media for 4 or 24 h, after an initial 30 min exposure, still blocks the TG-dependent Ca 2+ transients in these cells (Figure 9e) .
Northern blot analysis demonstrates that with increasing duration of exposure to TG, DR5 transcripts accumulate in HT29 cells (Figure 10 , lanes 1 ± 5), so that maximal levels occur by 4 h of treatment (Figure 10) , a point at which the ER Ca 2+ pools are depleted (Figure 9b ) (of note is that exposure to TG for as little as 30 min depletes the intracellular Ca 2+ pools to the same extent seen with 4 or 24 h incubations) (data not shown). Although the depleted state of ER Ca 2+ pools could serve as a potential trigger in regulating DR5 mRNA levels, the initial Ca 2+ transients induced by TG may also possibly regulate DR5 message. As shown in Figure  9d ,e, a short incubation of HT29 cells in BAPTAcontaining media can prevent TG-induced Ca transients. BAPTA by itself has minimal eects on DR5 mRNA accumulation ( Figure 11 , lanes 2 ± 3). However, if HT29 cells are exposed to BAPTA-AM for 30 min, and then incubated in TG-containing media for 4 h, DR5 mRNA levels are increased several fold (Figure 11, lane 4) . The 30 min exposure to BAPTA-AM prior to the 4 h TG incubation prevents any Ca 2+ transients from occurring ( Figure  9d ), although the ER Ca 2+ pools get depleted by the TG treatment. Thus, DR5 mRNA is increased irrespective of whether or not TG-induced Ca 2+ transients occur. Interestingly, DR5 mRNA levels appear to be higher in cells treated with BAPTA and TG compared to cells treated only with TG ( Figure  11, lanes 4, 5) . By chelating the cytosolic free Ca 2+ , conceivably BAPTA may allow for a more complete depletion of ER Ca 2+ pools with TG, which in turn could lead to the higher DR5 mRNA levels seen with the BAPTA/TG combination. Similar results were obtained in PC-3BM prostate cancer cells (data not shown) which con®rms that these results are not restricted to only one cell type. Furthermore, studies with a dierent SERCA pump inhibitor 2,5-Di-tbutylhydroquinone (DBHQ) also suggested a correlation between ER Ca 2+ pool depletion and DR5 expression (Figure 12a,b) . 
Discussion
In this study, we report our novel ®ndings that TG, an agent known to cause perturbations in intracellular Ca 2+ homeostasis, regulates DR5 and its ligand TRAIL. Studies have shown that TG, by aecting intracellular Ca 2+ homeostasis, can induce apoptosis in cultured cell lines (Furuya et al., 1994) . More recently, it has been demonstrated that TG-induced apoptosis is coupled with activation of caspase 9 and the down- Figure 9 Ca 2+ transients in response to TG in HT29 cells. Cells plated on glass coverslips were incubated with fura 2-AM for 10 min. TG 2 mM was added as shown by the bars. (a) control (i.e. no pre-treatment prior to adding TG); (b) cells pre-treated with TG 2 mM for 4 h prior to adding TG; (c) cells pre-treated with TG 2 mM for 4 h, then TG-containing media removed for 24 h prior to adding TG; (d) cells pre-treated with BAPTA (20 mM) for 30 min prior to adding TG; (e) cells pre-treated with BAPTA (20 mM) for 30 min, then BAPTA-containing media removed for 24 h prior to adding TG stream executioner caspases (Wertz and Dixit, 2000) . Caspase 9 activation is considered to be a postmitochondrial event since it is predominantly activated in response to apoptotic signals that engage the mitochondria and cause release of cytochrome c into the cytosol (reviewed by Gross et al., 2000) . Consistent with these ®ndings, our results indicate that TG does activate caspase 9. We also demonstrate, for the ®rst time, that TG engages the membrane death receptor pathway involving DR5/TRAIL and proximal caspase 8. Thus, it is likely that TG mediates its apoptotic eects via the DR5 pathway as well as the mitochondrial pathway. Given that caspase 8 is predominantly activated by signals originating at the membrane death receptors, including DR5, it is possible that TG may activate other death receptors besides DR5 to mediate its eects.
Recent evidence demonstrates that Bid, a Bcl-2 family member, can bridge apoptotic signals emanating from DRs and the mitochondria. For example, Bid is cleaved via death receptor-dependent activation of caspase 8 (Li et al., 1998; Luo et al., 1998) ; cleaved Bid translocates to the mitochondria and aects cytochrome c release and caspase 9 activation (Wei et al., 2000) . Our present results indicate that Bid is also cleaved during TG-mediated apoptosis. This ®nding, coupled with our other results, suggests that TG, by activating the death receptor-dependent pathway, also engages the mitochondrial events via caspase 8-dependent Bid cleavage.
TG selectively regulated DR5 but not the other TRAIL receptor, i.e. DR4. In general, DR5 and DR4 are co-expressed, and engage the same downstream apoptotic machinery (reviewed by Ashkenazi and Dixit, 1999; Schulze-Ostho et al., 1998) . The physiological rationale as to why cells express two functionally redundant death receptors remains unclear. Our demonstration that TG selectively regulates DR5 but not DR4 may provide some insight into why these two death receptors with redundant functions coexist within the same cells. For instance, it is possible that certain apoptotic stimuli mediate their eects by regulating only DR5, as we have shown for TG, while others would engage only DR4.
We investigated the mechanisms by which TG upregulates DR5 gene expression. The expression of certain genes can be modulated at the transcriptional level by elevations in cytosolic Ca 2+ . For instance, expression of the stress-response gene grp78 is enhanced by TG at the transcriptional level, and occurs as a consequence of TG-induced depletion of intracellular Ca 2+ stores rather than a rise in Ca 2+ within the cytosol (Li et al., 1993) . Unique response elements (RE) have been identi®ed within the grp promoter whose activity is modulated by TG and ionophores (Waser et al., 1997) . Similarly, the gene encoding calreticulin has been shown to harbor TGsensitive RE, and is also transcriptionally regulated by the status of intracellular Ca 2+ pools rather than cytosolic Ca 2+ (Waser et al., 1997) . The stability/ degradation of many mRNA species is dependent upon AUUUA-rich elements (ARE) that are present within their 3'-untranslated regions (UTRs) (Chen and Shyu, 1995) . Various exogenous factors including ionophores, can modulate ARE-directed mRNA degradation (Chen and Shyu, 1995) . As an example, Ca 2+ ionophores enhance GM-CSF mRNA stability by increasing the binding activity of speci®c AUUUAmRNA binding proteins (Ruth et al., 1999) . Thus, Ca 2+ dependent signals can also alter mRNA stability. Our results demonstrate that the TGmediated increase in DR5 mRNA levels involve post-transcriptional and transcriptional controls. Regulation of certain genes at both the transcriptional and post-transcriptional levels by the same agent has been reported. For example, growth arrest and DNA damage-inducible (GADD) genes are regulated transcriptionally and post-transcriptionally by the same stress-inducing agents (Jackman et al., 1994; Zhan et al., 1996) . Our results also demonstrate that DR5 mRNA levels increase in the presence of TG even when TGdependent Ca 2+ transients are blocked by the high anity Ca 2+ chelator BAPTA-AM (Figure 11 , lane 4). This suggests that the TG-mediated Ca 2+ transients are unlikely to participate in modulating DR5 mRNA levels. The other possibility is that the depleted state of the ER Ca 2+ pools, which occurs as a consequence of exposure to TG, could itself serve as a potential triggering signal in enhancing DR5 mRNA levels. Studies with the reversible SERCA pump inhibitor DBHQ further suggest that a correlation between ER Ca 2+ pool depletion and DR5 mRNA levels exists. DBHQ is known to be a less potent and reversible inhibitor of SERCA pumps. Consistent with this notion, only a modest increase in DR5 mRNA levels occurs with DBHQ-mediated ER Ca 2+ pool depletion, and as the Ca 2+ pools re®ll upon DBHQ removal the RNA levels return to baseline ( Figure  12b ). On the other hand, the irreversible inhibition of SERCA by TG results in the continued depletion of ER Ca 2+ pools even after TG removal, and the DR5 mRNA levels remain elevated above baseline under these conditions (Figures 9c and 10 , lane 6). The complexity with respect to the TG-mediated regulation of DR5 message and Ca 2+ pool status is underscored by the observation that DR5 mRNA levels decrease slightly from maximal upon removal of TG after an initial 4 h TG-treatment (Figure 10 , lane 6) even though the Ca 2+ pools remain depleted. Thus, in spite of the Ca 2+ pools remaining empty due to the irreversible inhibition of SERCA, other as yet unidenti®ed TG-dependent processes could potentially have recovered upon TG removal, resulting in the slight down-modulation of DR5 mRNA levels seen in Figure 10 , lane 6.
In summary, TG regulation of DR5 appears to occur predominantly as a consequence of ER Ca 2+ pool depletion that is induced by this agent. TG, by depleting the Ca 2+ pools within the ER storage compartments, in¯icts a form of ER-stress. Cellular stress that occurs due to disruption of ER physiology is known as ER-stress which can trigger certain responses, including (i) activation of the eIF2a kinases PERK and PKR to inhibit translation initiation, (ii) induction of adaptive responses (through enhanced transcription of genes) involved in protective functions and (iii) induction of apoptosis (reviewed by Kaufman, 1999) . The molecular mechanisms of ERstress-induced apoptosis remain poorly understood. Recent evidence suggests that transcriptional induction of the GADD153/CHOP gene is tightly coupled with ER-stress-induced apoptosis (Kaufman, 1999 and refs. therein) . GADD153/CHOP codes for a nuclear protein that dimerizes with C/EBP family members (Ron and Habener, 1992) . How GADD153/ CHOP might play a role in ER stress-induced apoptosis remains unclear. Our identi®cation of ERstress-dependent regulation of DR5 and its ligand TRAIL (the two bona ®de apoptosis inducing molecules) is a novel ®nding that links ER stress to apoptosis. Future studies will attempt to identify the ER stress-regulated molecules that modulate DR5 gene expression at the transcriptional and/or posttranscriptional levels.
Materials and methods
Materials
TG was purchased from Sigma Chemicals (St. Louis, MO, USA). Cell culture media, DMEM, was from GIBCO-BRL (Gaithersburg, MD, USA) and the fetal bovine serum was bought from Gemini Bioproducts (Calabasas, CA, USA) TRAIL was kindly provided by Dr Avi Ashkenazi (Genentech, San Francisco, CA, USA).
Cell lines and cell culture DU145, PC-3BM, TSU-Pr1 and ALVA31 are human prostate cancer cell lines; MCF-7 and T47D are human breast cancer cell lines; A549 and H1299 are human lung cancer cell lines; HT29 are human colon cancer cells; HL60 are human promyelocytic leukemia cells. All cells were regularly maintained in DMEM (GIBCO-BRL, Gaithersburg, MD, USA) supplemented with 10% foetal bovine serum (Gemini Bioproducts, Calabasas, CA, USA).
Analysis for apoptosis
Cells exhibiting morphologic characteristics of apoptosis were detected as we have previously reported (Sheikh et al., 1998a,b) . In brief,¯oating and adherent cells were ®xed with methanol, stained with DAPI (4-'diamidino-2-phenylindole) solution and analysed under a¯uorescent microscope using an appropriate ®lter. Cells displaying morphologic features of apoptosis, including chromatin condensation and nuclear fragmentation, were scored in 5 ± 10 randomly selected ®elds. For each sample, approximately 300 ± 1000 nuclei were examined, and the results were expressed as the number of apoptotic nuclei scored over the total number of nuclei counted.
Northern blotting
RNA extraction and Northern blot analyses were performed by standard procedures as we have described previously (Sheikh et al., 1998a) . A human DR5 cDNA was used as probe to assess DR5 RNA levels via Northern blots (Sheikh et al., 1998a) . To analyse DR4 expression, a RT ± PCR ampli®ed human DR4 cDNA fragment corresponding to the 3'-region was used as probe.
Luciferase assay
For luciferase assays plasmids carrying DR5 genomic promoter-and luciferase reporter gene were used (Takimoto and El-Deiry, 2000) . Luciferase assays were performed as we have previously described (Sheikh et al., 1994) . Brie¯y, MCF-7 cells growing in 35 mm plates were transfected with the reporter gene carrying vectors using LipofectAMINE 2000 (GIBCO-BRL, Gaithersburg, MD, USA). After overnight incubation, cells were washed and treated with 1 mM TG for 24 h. Cells were harvested, washed with 16 PBS and resuspended in potassium phosphate buer (100 mM, pH 7.8). Equal amounts of protein representing each sample were used in measuring luciferase activity using a luminometer.
Western blotting
Western blot analyses were performed by standard procedures as described previously (Sheikh et al., 1998b) . DR5 was detected using an anti-human DR5 antibody (Alexis Biochemicals, San Diego, CA, USA). The speci®city of the antibody was con®rmed by using recombinant DR5 protein as a positive control (R&D Systems, Minneapolis, MN, USA). To detect caspases 3, 8 and 9 activation, anti-human pro-caspase 3 (Transduction Laboratory, Lexington, KY, USA), anti-human pro-caspase 8 antibody (Pharmingen, San Diego, CA, USA) and anti-human pro-caspase 9 antibody (kindly provided by Dr Yuri Lazebnick, Cold Spring Harbor, NY, USA) were used. Anti-human PARP antibody (Pharmingen, San Diego, CA, USA) was used to detect PARP cleavage. Bid cleavage was detected by anti-Bid antibody purchased from R&D, Minneapolis, MN, USA.
Quantitative RT ± PCR
RT ± PCR was performed using SuperScript First Strand Synthesis System (Gibco-BRL, Gaitherburg, MD, USA) according to the manufacturer's instructions. For each reaction, approximately 2 mg of total RNA were used to synthesize the cDNAs, which were then diluted in series of 1 : 100, 1 : 1000 and 1 : 5000. PCR ampli®cation was performed using 5.25 ml of each diluted cDNA, one unit of Taq DNA polymerase (Promega), 10 nM of dNTP and 2.5 mM of MgCl 2 and 2.5 pmol of the following primers in 25 ml total volume: TRAIL-S (5'-TCTCAAGTAGTGTATCACAGTA-GT-3'); TRAIL-AS (5'-CGATTCTCCTGCCTCAGCCTCT-CA-3'); DR5-S (5'-GAGGAAGTTGGGCCTCATGGACA-A-3'); DR5-AS (5'-GTCTGACTTCCTGAAGAGAATCA-CA-3'); b-Actin-S (5'-TGTTTGAGACCTTCAACAC-CC-3'); b-Actin-AS (5'-AGCACTGTGTTGGCGTACAG-3').
Samples were subjected to 35 cycles of PCR ampli®cation. In each cycle denaturing was at 958C for 45 s, annealing at 618C for 45 s, and extension at 728C for 45 s. Ten ml aliquots of each PCR product were analysed on ethidium bromidecontaining 2% agarose gels.
Functional studies of intracellular Ca
2+
Cytosolic Ca 2+ in cells was monitored using¯uo-4 (¯uo-4/ AM, Molecular Probes, Eugene, OR, USA). Cells were loaded with 1 mM¯uo-4/AM for 10 min at room temperature in serum-free media. After incubation, dishes containing the cells were washed twice with Ringer's solution (10 mM HEPES, 140 mM NaCl, 2 mM KCl, 0.5 mM MgCl 2 , 1 mM CaCl 2 , 5.6 mM glucose, pH 7.3), and then mounted on the microscope in the same solution at room temperature. Cytosolic Ca 2+ transients were monitored in cells via an Olympus IX70 microscope with confocal scanning system (LasersharpNT, Bio-Rad.) using an excitation wavelength of 488 nm to detect¯uorescence at 510 nm. At least 30 cells were monitored simultaneously in each dish. Cytosolic Ca 2+ was calculated from¯uo-4 records using [Ca 2+ ]=K d (F-F MIN )/(F MAX -F), with K d =345 nM and F (¯uorescence for excitation)=488 nm. F MAX and F MIN were determined for each cell monitored in every dish. To determine F MAX 10 mM ionomycin was applied in Ringer's solution with 5 mM Ca 2+ . F MIN was calculated by adding 2 mM Mn 2+ and 10 mM ionomycin in Ringer's solution. Background¯uorescence at the relevant wavelengths was determined for each plate. All background correction, data processing, and analysis were performed with customized software programmed in Interactive Data Language (Research Systems Inc., Boulder, CO, USA).
